Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
immunotherapy
Manufacturing
Merck's BCG monopoly could end
ImmunityBio's newly approved Anktiva must be used alongside BCG, which is solely supplied by the company's competitor in bladder cancer, Merck & Co.
Angus Liu
May 3, 2024 10:50am
Soon-Shiong's ImmunityBio bags FDA nod for bladder cancer drug
Apr 22, 2024 10:40pm
AZ, GSK make case for broad I-O uses in endometrial cancer
Mar 18, 2024 11:05am
Exelixis joins Novartis on FDA waiting list in prostate cancer
Jan 25, 2024 8:00am
BMS shows I-O duo's power in first-line colorectal cancer
Jan 20, 2024 10:00am
Sanofi back on M&A trail with $2.9B deal for Provention
Mar 13, 2023 9:18am
